Header Logo

Connection

ERNESTINA MELICOFF-PORTILLO to Palivizumab

Back to Details
This is a "connection" page, showing publications ERNESTINA MELICOFF-PORTILLO has written about Palivizumab.
ERNESTINA MELICOFF-PORTILLO
Connection Strength
0.046
Palivizumab
  1. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.